Valproate, a Mood Stabilizer, Induces WFS1 Expression and Modulates Its Interaction with ER Stress Protein GRP94

Chihiro Kakiuchi, Shinsuke Ishigaki, Christine M. Oslowski et al. · 2009

Read Valproate, a Mood Stabilizer, Induces WFS1 Expression and Modulates Its Interaction with ER Stress Protein GRP94 by Chihiro Kakiuchi, Shinsuke Ishigaki, Christine M. Oslowski et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004134.txt.

Description

Chihiro Kakiuchi and colleagues published this study in PLOS ONE in 2009. Valproate is a standard drug for bipolar disorder and a first-line mood stabiliser, yet how it works in the brain is still unclear. One clue is that it changes gene activity. It also switches on proteins that help cells handle stress in the endoplasmic reticulum, a cell compartment where proteins are folded.

The team reports that valproate raises production of WFS1, a gene also known from a rare form of diabetes. They also show it changes how WFS1 interacts with GRP94, a protein tied to that same stress system. The findings offer one concrete path by which the drug may calm mood swings.

Catalog record

CREATORChihiro Kakiuchi, Shinsuke Ishigaki, Christine M. Oslowski et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE21 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004134

Browse the full library · About the Tower of Babel